Sort
48,018 grants matching “immunotherapy”
Developing broad-spectrum therapeutics against C. difficile toxins
$798,535Rongsheng Jin · University Of California-Irvine · R01 · FY2021 · AI
Microglia-Amyloid interactions in delirium superimposed on dementia
$798,413Niccolo Terrando · Duke University · R01 · FY2025 · AG
Natural killer cell engineering to target the HIV reservoir
$798,248Jerome A. Zack · University Of California Los Angeles · R01 · FY2021 · AI
Assessment of ultrasound-facilitated neurotherapeutics in Alzheimer's disease
$798,155Elisa E Konofagou · Columbia University Health Sciences · R56 · FY2023 · AG
The Role of Food Sensitization in Cardiovascular Disease
$798,090Corinne Keet · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$798,050Katerina Abigail Politi · Yale University · U01 · FY2020 · CA
Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)
$798,011Antony Rosen · Johns Hopkins University · P30 · FY2023 · AR
Immunosurveillance of breast glands with oncogenic germline mutations
$797,986Shadmehr Demehri · Massachusetts General Hospital · UG3 · FY2024 · CA
Immunosurveillance of breast glands with oncogenic germline mutations
$797,986Shadmehr Demehri · Massachusetts General Hospital · UG3 · FY2025 · CA
AUTOIMMUNITY--MECHANISMS OF UNRESPONSIVENESS
$797,914Stanford University · P01 · FY2001 · AI
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$797,767Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial Stress
$797,728Kira O. Bona · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Hepatitis C: Studies of Immunity and Pathogenesis
$797,618Charles M. Rice · Rockefeller University · U19 · FY2008 · AI
Immune epigenetic biomarkers of survival in glioma epidemiology
$797,441John K. Wiencke · University Of California, San Francisco · R01 · FY2020 · CA
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE
$797,395Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2020 · AI
Mayo Clinic Breast Cancer SPORE
$797,371Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2021 · CA
Immunotherapy of inflammation, autoimmune disease and cancer
$797,203Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
Topical proprietary biologic to treat oral mucositis
$797,137Christian Young · Allander Biotechnologies, Inc. · R44 · FY2017 · DE
The IL-18-IFNγ axis predicts response to immunotherapy
$797,116Heather Leigh Herd Gustafson · Seattle Children'S Hospital · R37 · FY2025 · CA
UNDERSTANDING T-CELL SENESCENCE TO OPTIMIZE OVARIAN CANCER IMMUNOTHERAPY
$797,100Centre Hospitalier Universitaire Vaudois (Chuv) · · FY2022 · Department of the Army
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease
$797,087Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2020 · AG
CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
$796,925James J Chou · Harvard Medical School · R01 · FY2021 · AI
Epigenetic Therapy for Thoracic Malignancies
$796,884David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Advancing treatment and understanding of immunotherapy in glioblastoma
$796,871Nicholas A Butowski · University Of California, San Francisco · U19 · FY2024 · CA
Posttranscriptional control of gene expression
$796,657Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA